New protein test could sharpen leukemia diagnosis

NCT ID NCT07313982

Recruiting now Knowledge-focused Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna Source: ClinicalTrials.gov ↗

First seen Jan 07, 2026 · Last updated May 14, 2026 · Updated 18 times

Summary

This study examines the LEF-1 protein in tissue samples from 350 adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The goal is to see if measuring LEF-1 helps doctors diagnose these diseases more accurately and identify new markers for prognosis or treatment. Participants must already have had their tissue tested for LEF-1 and other genetic data.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) / SMALL LYMPHOCYTIC LYMPHOMA (SLL) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Irccs Azienda Ospedaliero-Universitaria Di Bologna
RECRUITING

Bologna, BOLOGNA, 40138, Italy

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) / SMALL LYMPHOCYTIC LYMPHOMA (SLL)